Stockscreener 앱 받기
12.76
6.04%
-0.82
시간 외 거래:
13.14
0.385
+3.02%
Alpha Tau Medical Ltd 주식(DRTS)의 최신 뉴스
Alpha Tau Medical stock tracks a thin session. Investors watch its listing and filings. - AD HOC NEWS
Alpha Tau Medical: Alpha Particles Are Still Interesting, But Beware The Hype (NASDAQ:DRTS) - Seeking Alpha
Alpha Tau Medical (DRTS) CFO trades 2,270 shares in exercise and sale - Stock Titan
Enterprise value to revenue forward of Alpha Tau Medical Ltd. – NASDAQ:DRTS - TradingView
Price to sales forward of Alpha Tau Medical Ltd. – BOATS:DRTS - TradingView
Insider Sell: Raphi Levy Sells Shares of Alpha Tau Medical Ltd (DRTS) - GuruFocus
Alpha Tau Medical (DRTS) Is Up 17.9% After First International Alpha DaRT Glioblastoma Procedure – Has The Bull Case Changed? - simplywall.st
Alpha Tau Medical (DRTS) notice: 20,000 shares from option exercise to be sold - Stock Titan
Alpha Tau Medical (DRTS) CFO exercises 17,873 options and sells 17,873 shares - Stock Titan
Alpha Tau Medical (DRTS) price target increased by 15.15% to 9.69 - MSN
Alpha Tau Medical (NASDAQ: DRTS) CFO sells 2,127 shares after exercising options - Stock Titan
Form 144 Alpha Tau Medical Ltd. For: 2 July By Investing.com - Investing.com Canada
Levy Raphi to sell 20,000 Alpha Tau shares (DRTS) via Form 144 - Stock Titan
Alpha Tau Medical Ltd. Warrant 2022-07.03.27 on Alpha Tau Med Rg-A Financial Disclosures & SEC Filings - TradingView
DRTS Stock Price, Quote & Chart - ChartMill
Insider Sell: Raphi Levy Sells 20,000 Shares of Alpha Tau Medica - GuruFocus
Alpha Tau Medical (DRTS) CFO sells 20,000 shares, retains 90,180 - Stock Titan
Alpha Tau Medical stock hits 52-week high at $11.64 By Investing.com - Investing.com South Africa
Alpha Tau Medical stock hits 52-week high at $11.64 - Investing.com UK
Form 144 Alpha Tau Medical Ltd. For: 30 June By Investing.com - Investing.com South Africa
Insider sells 37,500 shares at Alpha Tau Medical (NASDAQ: DRTS) - Stock Titan
H.C. Wainwright Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Maintains Target Price $15 - Moomoo
Why Alpha Tau Medical (DRTS) Is Up 11.2% After First Alpha DaRT Brain-Tumor Procedure News - Sahm
Alpha Tau Medical’s (DRTS) First International Brain Cancer Use Tests The Breadth Of Its Alpha DaRT Platform - Yahoo Finance
Form 144 Alpha Tau Medical Ltd. For: 26 June By Investing.com - Investing.com South Africa
Alpha Tau Medical (DRTS) CFO sells 20,000 Ordinary Shares - Stock Titan
Raphi Levy sale: 17,500 shares disclosed for Alpha Tau Medical (DRTS) - Stock Titan
Alpha Tau Medical (DRTS) Looks Fully Priced After Its Glioblastoma Treatment Milestone - simplywall.st
Alpha Tau Medical (NASDAQ: DRTS) shareholders back board, pay and auditor at AGM - Stock Titan
Alpha Tau Medical Ltd Actuals & Estimates (NASDAQ:DRTS) - TradingView
Insider Sell Alert: Raphi Levy Sells Shares of Alpha Tau Medical Ltd (DRTS) - GuruFocus
DRTS Forecast — Price Target — Prediction for 2027 - TradingView
Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic Portfolio Appreciation, and a Strengthened Balance Sheet - PR Newswire
Alpha Tau Medical (DRTS) CFO reports open-market sale of 17,500 shares - Stock Titan
Alpha Tau Medical Ltd (DRTSW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
symbol__ Stock Quote Price and Forecast - CNN
Alpha Tau Medical Ltd (DRTSW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Form 6K Alpha Tau Medical Ltd For: 23 June By Investing.com - Investing.com India
Alpha Tau Treats First Recurrent Glioblastoma Patient Outside U.S. With Alpha DaRT in Israel - TipRanks
Alpha Tau Medical (Nasdaq: DRTS) treats first recurrent glioblastoma patient outside U.S. - Stock Titan
Form 144 Alpha Tau Medical Ltd. For: 23 June By Investing.com - Investing.com Australia
Alpha Tau first treats glioblastoma patient outside the U.S. in Israel - Stock Titan
Alpha Tau Medical (DRTS) Form 144: Director plans sale of 17,500 shares on Nasdaq - Stock Titan
1.17%
2.48%
자본화:
|
볼륨(24시간):